Centrient Pharmaceuticals is the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.
Worldwide our employees work together to deliver cutting edge generics solutions that help to keep our customers ahead of the competition.
Headquartered in Rotterdam (Netherlands), we have manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico.
News
1 May, 2019
Centrient Pharmaceuticals Initiates Patent Litigation in India Against Dalas Biotech Limited
25 February, 2019
Effective May 6th 2019, Ronald Merckx will be joining Centrient Pharmaceuticals as Chief Financial Officer and member of the Executive Committee and Management Board of Directors.
18 February, 2019
The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals
10 December, 2018
DSM Sinochem Pharmaceuticals announces its new name - Centrient Pharmaceuticals
31 October, 2018
Our former shareholders of Royal DSM and the Sinochem Group have now successfully completed the sale of DSP to Bain Capital as of October 31, 2018
PureActives
Copyright © 2018 Centrient Pharmaceuticals
Join the conversation